Bovine Mastitis Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Diagnostics), By Route Of Administration (Intra-Mammary, Systemic), By Therapy, By Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Bovine Mastitis Market Growth & Trends

The global bovine mastitis market size is expected to reach USD 2.66 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.26% from 2025 to 2030. The market is driven by various factors, such as the increasing prevalence of bovine mastitis, rising demand for dairy products, and growing adoption of preventive measures. Mastitis is a common infection among dairy cows, significantly affecting milk yield and quality. The growing awareness of this disease and its economic implications is driving the demand for effective diagnostics and treatments.

Technological advancements in diagnosis are another factor fueling market growth. For example, according to the Journal of Veterinary Diagnostic Investigation, bovine mastitis is an economic hardship for dairy producers, and preventive management strategies are critical to the long-term viability of any dairy business. Recent advances in technology, including transcriptome and proteome studies, as well as nano- and micro-manufacturing of handheld devices, provide promising, sensitive ways for detecting mastitis bacteria and inflammation biomarkers. As farms grow in size, there is an increasing need for innovative, quick, and accurate diagnostic techniques. The microarray technology, which can identify seven prevalent species of mastitis-causing pathogens in 6 hours with a reported sensitivity of 94.1% and specificity of 100%, is another technological advancement of genotypic approaches for the identification of bovine mastitis pathogens.

Increasing demand for dairy related products helps in strengthening the market growth. According to OECD estimations from 2020 to 2029, almost 80% of the world's milk production comes from cow milk. By 2029, it is anticipated that China and India will account for over 30% of the world's milk production. In addition, according to the OECD projects, between 2022 and 2031, global consumption of milk, fresh dairy products, butter, and cheese would rise. For example, it is anticipated that cheese consumption will increase from 25,500 kt pw in 2022 to 28,136 kt pw in 2031. According to figures released by the Press Information Bureau of India in May 2024, milk production in India grew at a CAGR of more than 6%, from 187.30 million tons in 2018 - 2019 to 230.58 million tons in 2022 - 2023. Hence, these factors are propelling market growth.

Bovine Mastitis Market Report Highlights

  • Based on product, the pharmaceutical segment dominated the market in 2024. While the diagnostics segment is anticipated to grow at the fastest CAGR over the forecast period due to technological advancements in diagnosis.
  • In terms of type, clinical mastitis held the largest market share in 2024, and sub-clinical mastitis is expected to grow at the fastest CAGR over the forecast period.
  • Based on therapy, the dry period segment held the largest market share in 2024.
  • In terms of route of administration, the intra-mammary segment dominated the market in 2024 because it effectively targets the infection inside the udder.
  • Based on end use, the veterinary hospitals/clinics segment accounted for the largest revenue share in 2024 due to their critical involvement in the diagnosis, treatment, and prevention of udder infection.
  • North America dominated the global market in the year 2024. The factors driving the regional market growth include the rising cattle population and the increasing desire to satisfy consumer demands for sustainable animal protein sources.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. Therapy
1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Bovine Mastitis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of bovine mastitis
3.2.1.2. Technological advancements in diagnosis
3.2.1.3. Rising demand of dairy products
3.2.2. Market Restraint Analysis
3.2.2.1. Increase in antibiotic resistance
3.3. Market Opportunity Analysis
3.4. Market Challenge Analysis
3.5. Business Environment Analysis
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTLE Analysis
3.5.3. Regulatory Framework
3.5.4. Estimated Cattle Population, by Key Species, Key Country (2024)
3.5.5. Pricing Analysis
3.5.6. COVID-19 Impact Analysis
Chapter 4. Bovine Mastitis Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Pharmaceuticals
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Antibiotics
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Vaccines
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Diagnostics
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Bovine Mastitis Market: Type Business Analysis
5.1. Type Market Share, 2024 & 2030
5.2. Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Clinical
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Sub-Clinical
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Bovine Mastitis Market: Therapy Business Analysis
6.1. Therapy Market Share, 2024 & 2030
6.2. Therapy Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
6.4. Dry Period
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Lactating Period
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Bovine Mastitis Market: Route of Administration Business Analysis
7.1. Route of Administration Market Share, 2024 & 2030
7.2. Route of Administration Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
7.4. Intra-Mammary
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Systemic
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Bovine Mastitis Market: End Use Business Analysis
8.1. End Use Market Share, 2024 & 2030
8.2. End Use Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Veterinary Hospitals/Clinics
8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Others
8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Bovine Mastitis Market: Regional Estimates & Trend Analysis by Product, Type, Therapy, End Use, and End Use
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. U.S. Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Canada Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Mexico Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5. Europe
9.5.1. Europe Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. UK Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Germany Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. France Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Italy Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Spain Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Norway Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key country dynamics
9.5.8.2. Denmark Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.9. Sweden
9.5.9.1. Key country dynamics
9.5.9.2. Sweden Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Japan Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. China Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. India Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key country dynamics
9.6.5.2. South Korea Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.6. Australia
9.6.6.1. Key country dynamics
9.6.6.2. Australia Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Thailand Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Brazil Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Argentina Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.8. MEA
9.8.1. MEA Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. South Africa Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Saudi Arabia Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. UAE Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Kuwait Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Boehringer Ingelheim Animal Health
10.5.1.1. Overview
10.5.1.2. Financial performance
10.5.1.3. Product benchmarking
10.5.1.4. Strategic initiatives
10.5.2. Zoetis
10.5.2.1. Overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. Ceva
10.5.3.1. Overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. Merck & Co., Inc.
10.5.4.1. Overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. Elanco
10.5.5.1. Overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Immucell Corporation
10.5.6.1. Overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. Virbac.
10.5.7.1. Overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Forte Healthcare Ltd
10.5.8.1. Overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. HIPRA
10.5.9.1. Overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. Heilsaa
10.5.10.1. Overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
Chapter 11. Key Takeaways

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings